Impact BioMedical, Inc. Common Stock
Key Metrics
Market Snapshot
About
Impact BioMedical Inc. (IBO) is a Houston-based biotechnology company focused on developing and commercializing novel health and wellness products. The company is best known for its portfolio of proprietary technologies targeting therapeutic and consumer applications.
The company's approach involves discovering and developing unique compounds. Its main technology platform, called Linebacker, consists of small molecule polyphenol compounds designed for potential use in areas such as oncology, inflammation, and neurology. Another key technology, Laetose, is derived from a combination of sugar and inositol and is intended to inhibit certain inflammatory and metabolic responses. Additionally, the company is developing antiviral technologies under the Equivir name, which blend polyphenols for use in supplements or medications.
Impact BioMedical also works on formulations for consumer markets. It has a functional fragrance formulation that incorporates botanical ingredients intended for antimicrobial use or as additives in products like insect repellents, detergents, and lotions. The company aims to address unmet needs across several segments, including specialty biopharmaceuticals, antivirals, antimicrobials, and general consumer healthcare. Incorporated in 2018, Impact BioMedical operates as a subsidiary of DSS BioHealth Security, Inc.